238 related articles for article (PubMed ID: 24013661)
1. High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.
Kraan W; Horlings HM; van Keimpema M; Schilder-Tol EJ; Oud ME; Scheepstra C; Kluin PM; Kersten MJ; Spaargaren M; Pals ST
Blood Cancer J; 2013 Sep; 3(9):e139. PubMed ID: 24013661
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and prognostic value of
Kirkegaard MK; Minderman M; Sjö LD; Pals ST; Eriksen PRG; Heegaard S
Br J Ophthalmol; 2023 Apr; 107(4):576-581. PubMed ID: 34706861
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice.
Visco C; Tanasi I; Quaglia FM; Ferrarini I; Fraenza C; Krampera M
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050534
[TBL] [Abstract][Full Text] [Related]
4. Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations.
Yamada S; Ishida Y; Matsuno A; Yamazaki K
Leuk Lymphoma; 2015 Jul; 56(7):2141-5. PubMed ID: 25347427
[TBL] [Abstract][Full Text] [Related]
5. Prevalence And Clinical Significance Of Oncogenic
Chen YP; Ke LF; Lu JP; Wang JC; Zhu WF; Chen FF; Lin SF; Xu CW; Wu MJ; Chen G
Onco Targets Ther; 2019; 12():10165-10175. PubMed ID: 32063711
[TBL] [Abstract][Full Text] [Related]
6.
Vermaat JS; Somers SF; de Wreede LC; Kraan W; de Groen RAL; Schrader AMR; Kerver ED; Scheepstra CG; Berenschot H; Deenik W; Wegman J; Broers R; de Boer JD; Nijland M; van Wezel T; Veelken H; Spaargaren M; Cleven AH; Kersten MJ; Pals ST
Haematologica; 2020; 105(2):424-434. PubMed ID: 31123031
[TBL] [Abstract][Full Text] [Related]
7. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
[TBL] [Abstract][Full Text] [Related]
8. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
[TBL] [Abstract][Full Text] [Related]
9. Patients with primary breast and primary female genital tract diffuse large B cell lymphoma have a high frequency of MYD88 and CD79B mutations.
Cao XX; Li J; Cai H; Zhang W; Duan MH; Zhou DB
Ann Hematol; 2017 Nov; 96(11):1867-1871. PubMed ID: 28803429
[